HMGB1 binds to activated platelets via platelet-expressed receptor for advanced glycation end products (RAGE) and is highly expressed in platelet rich coronary artery thrombi

被引：0
|
作者：
Ahrens, I. [1 ]
Agrotis, A. [2 ]
Topcic, D. [2 ]
Bassler, N. [2 ]
Chen, Y. C. [2 ]
Bobik, A. [2 ]
Bode, C. [1 ]
Peter, K. [2 ]
机构：
[1] Univ Freiburg, Dept Cardiol & Angiol, D-79106 Freiburg, Germany
[2] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia
来源：
EUROPEAN HEART JOURNAL | 2012年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：278 / 278
页数：1
相关论文
共 21 条
  • [1] HMGB1 binds to activated platelets via the receptor for advanced glycation end products and is present in platelet rich human coronary artery thrombi
    Ahrens, Ingo
    Chen, Yung-Chih
    Topcic, Danijal
    Bode, Michael
    Haenel, David
    Hagemeyer, Christoph E.
    Seeba, Hannah
    Duerschmied, Daniel
    Bassler, Nicole
    Jandeleit-Dahm, Karin A.
    Sweet, Matthew J.
    Agrotis, Alex
    Bobik, Alex
    Peter, Karlheinz
    THROMBOSIS AND HAEMOSTASIS, 2015, 114 (05) : 994 - 1003
  • [2] The Pro-Atherogenic DNA-Binding Cytokine HMGB1 Binds to Activated Platelets via the Receptor for Advanced Glycation End Products (RAGE) and Toll-Like Receptor 2 (TLR 2)
    Ahrens, Ingo
    Agrotis, Alex
    Topcic, Denijal
    Bassler, Nicole
    Chen, Yung-Chih
    Bobik, Alex
    Bode, Christoph
    Peter, Karlheinz
    CIRCULATION, 2011, 124 (21)
  • [3] Heparan Sulfate Is Essential for High Mobility Group Protein 1 (HMGB1) Signaling by the Receptor for Advanced Glycation End Products (RAGE)
    Xu, Ding
    Young, Jeffrey
    Song, Danyin
    Esko, Jeffrey D.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (48) : 41736 - 41744
  • [4] RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS (RAGE) IS NOT REQUIRED FOR INDUCTION OF LIPOTEICHOIC ACID (LTA) TOLERANCE BY HIGH MOBILITY GROUP BOX 1 (HMGB1)
    Robert, Stephen
    Sjodin, Hanna
    Fink, Mitchell
    Aneja, Rajesh
    CRITICAL CARE MEDICINE, 2009, 37 (12) : A55 - A55
  • [5] High-mobility Group B1 (HMGB1) and Receptor for Advanced Glycation End-products (RAGE) Expression in Canine Lymphoma
    Sterenczak, Katharina A.
    Joetzke, Alexa E.
    Willenbrock, Saskia
    Eberle, Nina
    Lange, Sandra
    Junghanss, Christian
    Nolte, Ingo
    Bullerdiek, Joern
    Simon, Daniela
    Escobar, Hugo Murua
    ANTICANCER RESEARCH, 2010, 30 (12) : 5043 - 5048
  • [6] Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1)
    van Beijnum, Judy R.
    Buurman, Wim A.
    Griffioen, Arjan W.
    ANGIOGENESIS, 2008, 11 (01) : 91 - 99
  • [7] Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1)
    Judy R. van Beijnum
    Wim A. Buurman
    Arjan W. Griffioen
    Angiogenesis, 2008, 11 : 91 - 99
  • [8] High motility group box 1 (HMGB1) protein and its receptor for advanced glycation end products (RAGE) expression in chronic rhinosinusitis without nasal polyps
    Dzaman, Karolina
    Zagor, Mariola
    Molinska-Glura, Marta
    Krzeski, Antoni
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2015, 53 (01) : 70 - 78
  • [9] Clinical Implications of High-mobility Group Box-1 (HMGB1) and the Receptor for Advanced Glycation End-products (RAGE) in Cutaneous Malignancy: A Systematic Review
    Austin Huy Nguyen
    Detty, Shannon Q.
    Agrawal, Devendra K.
    ANTICANCER RESEARCH, 2017, 37 (01) : 1 - 7
  • [10] Co-expression of High-mobility group box 1 protein (HMGB1) and receptor for advanced glycation end products (RAGE) in the prognosis of esophageal squamous cell carcinoma
    Li, Lingzhao
    Beeraka, Narasimha M.
    Xie, Linsen
    Dong, Li
    Liu, Junqi
    Wang, Lei
    DISCOVER ONCOLOGY, 2022, 13 (01)
123